Building an economic case for the equitable distribution of COVID-19 vaccines in developing nations
Sector: Philanthropy

Challenge: Ensuring equitable access to COVID-19 vaccines to serve public health, the economy, and the common good. 

What we delivered: An in-depth study of how various vaccine distribution scenarios would affect lower income countries, and a business case for equitable distribution.

Context and results:  With approvals for COVID-19 vaccines around the corner, our client was one of many voices calling for an equitable distribution of vaccines, especially to developing nations. These words often fell on deaf ears, with most nations competing for doses to end the pandemic domestically. As a key player in COVID-19 vaccine development, our client – a global non-profit – worked with PRISM to outline the economic impact of different vaccine distribution scenarios to support its advocacy efforts with key policymakers around the world.

Our analysis revealed that by only focusing on their own vaccine programs, wealthy nations would cause unnecessarily high death tools in lower income nations and prolong the pandemic for everyone. By contrast, a more egalitarian approach to global vaccine distribution would lead to billions in additional revenue from imports, tourism, and other major economic activities.

Armed with this information and industry-specific insights, our client was able to target and tailor its message for key policymakers, media, and the public, backing up its case with hard data.